Tuesday 23 June 2026
FTSE 100 10,360.54 -1.27%FTSE 250 22,879.42 -1.92%UK FTSE All Share 5,566.11 -1.34%FTSE Small Cap 7,830.39 -0.87%FTSE AIM All-Share Index 784.91 -2.37%Microsoft 367.34 -5.99%NVIDIA 208.65 +1.69%Apple 297.01 +2.02%Tesla 405.05 -0.34%Amazon 232.79 -2.41%Google 348.78 -2.62%S&P 500 7,472.79 +0.56%Nasdaq 26,166.60 +1.07%Dow 51,712.71 +1.00%Russell 2000 3,004.40 +2.05%CBOE Volatility Index 20.08 +8.89%US 10Y Treasury 4.51% +0.90%US 30Y Treasury 4.95% -0.48%US 5Y Treasury 4.29% +2.36%US 13w Treasury 3.68% +1.71%Euro Stoxx 50 6,233.95 -1.05%DAX 24,803.36 -0.43%CAC 40 8,327.86 -1.22%AEX-Index 1,066.35 -1.51%IBEX 35 19,497.00 +0.39%Nikkei 225 69,788.38 -0.16%Hang Seng 23,349.99 -6.01%SSE Composite Index 4,106.25 +0.35%Taiwan Weighted 47,100.65 +2.82%KOSPI Composite Index 8,203.84 -5.99%Gold $4,132.70 -5.19%Silver $62.45 -11.67%Brent Crude Oil $76.88 -3.36%Natural Gas $3.28 +4.39%Copper $6.20 -4.42%Dollar Index 101.04 +0.95%GBP/USD 1.3229 -1.47%GBP/EUR 1.1582 +0.16%GBP/AUD 1.9032 +0.17%EUR/USD 1.1419 -1.65%Bitcoin (USD) $62,869 -1.06%Ethereum (USD) $1,687 -1.41%XRP (USD) $1.1130 -2.06%Solana (USD) $70.16 +0.63%TRON (USD) $0.3314 +2.39%FTSE 100 10,360.54 -1.27%FTSE 250 22,879.42 -1.92%UK FTSE All Share 5,566.11 -1.34%FTSE Small Cap 7,830.39 -0.87%FTSE AIM All-Share Index 784.91 -2.37%Microsoft 367.34 -5.99%NVIDIA 208.65 +1.69%Apple 297.01 +2.02%Tesla 405.05 -0.34%Amazon 232.79 -2.41%Google 348.78 -2.62%S&P 500 7,472.79 +0.56%Nasdaq 26,166.60 +1.07%Dow 51,712.71 +1.00%Russell 2000 3,004.40 +2.05%CBOE Volatility Index 20.08 +8.89%US 10Y Treasury 4.51% +0.90%US 30Y Treasury 4.95% -0.48%US 5Y Treasury 4.29% +2.36%US 13w Treasury 3.68% +1.71%Euro Stoxx 50 6,233.95 -1.05%DAX 24,803.36 -0.43%CAC 40 8,327.86 -1.22%AEX-Index 1,066.35 -1.51%IBEX 35 19,497.00 +0.39%Nikkei 225 69,788.38 -0.16%Hang Seng 23,349.99 -6.01%SSE Composite Index 4,106.25 +0.35%Taiwan Weighted 47,100.65 +2.82%KOSPI Composite Index 8,203.84 -5.99%Gold $4,132.70 -5.19%Silver $62.45 -11.67%Brent Crude Oil $76.88 -3.36%Natural Gas $3.28 +4.39%Copper $6.20 -4.42%Dollar Index 101.04 +0.95%GBP/USD 1.3229 -1.47%GBP/EUR 1.1582 +0.16%GBP/AUD 1.9032 +0.17%EUR/USD 1.1419 -1.65%Bitcoin (USD) $62,869 -1.06%Ethereum (USD) $1,687 -1.41%XRP (USD) $1.1130 -2.06%Solana (USD) $70.16 +0.63%TRON (USD) $0.3314 +2.39%
Advertisement
Follow News in 60 on Facebook
UK Weather
London 21°C Patchy rain nearbyBirmingham 20°C SunnyManchester 22°C SunnyNewcastle 20°C Partly CloudyBristol 22°C SunnyCardiff 22°C SunnyEdinburgh 17°C Patchy rain nearbyBelfast 21°C Partly Cloudy

Nigeria’s Sugar Tax: Erosion of Health Policy Amid Inflation

Advertisement
Follow News in 60 on Facebook

Nigeria’s sugar tax, introduced to combat rising diabetes rates, is losing its effectiveness due to soaring inflation. Initially set at 10 Naira per liter, the tax has become negligible as inflation drives up beverage prices, making it less impactful on consumer behaviour. Experts argue that the tax, which now represents only 2% of retail prices, is insufficient to deter sugary drink consumption.

The rising cost of living has led to a significant increase in the price of soft drinks, with many Nigerians facing doubled costs. This inflationary pressure has overshadowed the intended health benefits of the sugar tax, which was designed to generate revenue for healthcare while reducing sugar intake. The tax’s fixed nature means it does not adjust for inflation, further diminishing its relevance.

Health advocates suggest that increasing the tax to 130 Naira per liter could lead to a substantial decrease in sugary beverage consumption. However, the beverage industry has resisted such reforms, citing potential job losses and operational costs. This pushback highlights the ongoing tension between public health initiatives and economic concerns in Nigeria.

Countries like Mexico have successfully implemented similar taxes, resulting in decreased consumption rates. Experts recommend that Nigeria’s tax be indexed to inflation and tied to health budgets to ensure its effectiveness. Without these changes, the sugar tax risks becoming a mere formality rather than a robust public health strategy.

Source: DW News

Read more Health news →

Leave a comment

Your email address will not be published. Required fields are marked *